The inaugural AACR Pediatric Cancer Progress Report highlights research-driven advances in the prevention, detection, and treatment of pediatric cancer.
Read the Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreScreening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the ReportMore than 67,000 people in the United States were diagnosed with pancreatic cancer this year. Learn about the treatment options for this type of cancer.
Learn MoreIn this episode of Believe in Progress, pickleball legend Steve Dawson talks about facing a prostate cancer diagnosis with the same competitive spirit he brings to the court.
Listen and SubscribeUseful information for cancer patients and their families, survivors, caregivers, advocates, and others from Cancer Today magazine.
Learn MoreYour donation to the American Association for Cancer Research today will support AACR grant giving to fund promising projects by early-career investigators.
Donate NowEarly registration is now open. Register by Monday, January 5, to receive the lowest rates.
The AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More